Stocks · Korea 303810 KOSDAQ

DongKook Life Science

2,750원 -1.96% Market cap 880억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER10.00x
PBR0.67x
EPS275 KRW
BPS4,107 KRW
ROE6.52%
DPS0 KRW

Returns and 52-week range

1W-9.54%
1M+20.35%
3M+12.24%
6M-25.47%
1Y-36.64%
YTD-25.47%
52W high4,325원
52W low2,155원
From 52W high-36.42%

Financial results (separate)

PeriodRevenueOperating incomeNet incomeOP margin
20241,318억119억22억9.0%
20251,303억130억87억10.0%
Quarterly
2025 1Q351억31억22억8.8%
2025 2Q349억32억29억9.2%
2025 3Q294억43억24억14.5%
2025 4Q310억25억11억7.9%
2026 1Q331억34억23억10.4%

Company

CEO박재원
Founded2017-05-01
Fiscal year end12
Websitedkls.co.kr
Address: 서울특별시 강남구 테헤란로108길 7

Peers in the same sector

CompanyMarket capP/EP/B1M
삼아제약891억6.600.37+0.29%
바이오에프디엔씨862억12.671.21+9.58%
국제약품937억15.820.96+30.87%
중앙백신853억14.040.81-0.86%
위더스제약942억18.990.96+2.28%
대봉엘에스845억8.290.59-4.51%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.